Cargando…
Role of Tissue Plasminogen Activator for Diffuse Pulmonary Microemboli in Coronavirus Disease 2019 Patient
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)–related hypercoagulability has been of great interest in the pathophysiology of coronavirus disease 2019 (COVID-19). Many patients have clinical findings of dead-space ventilation, similar to pulmonary embolism. Herein, a patient who prese...
Autores principales: | Ghia, Samit, Bhatt, Himani, Lazar, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7457935/ https://www.ncbi.nlm.nih.gov/pubmed/32962933 http://dx.doi.org/10.1053/j.jvca.2020.08.063 |
Ejemplares similares
-
“Anesthesia Stat” to Intubate a Coronavirus Disease 2019 (COVID-19) Patient: Implications for the Anesthesiologist
por: Ghia, Samit, et al.
Publicado: (2020) -
Oesophagus cancer, secondary cardiac tumour, and pulmonary microemboli
por: Tanaka, Yutaka, et al.
Publicado: (2022) -
Rotational thromboelastometry in young, previously healthy patients with SARS-Cov2
por: Lazar, Michael, et al.
Publicado: (2020) -
Role of low-dose tissue plasminogen activator in patients with refractory hypoxia due to presumed microthrombi in pulmonary vasculature in coronavirus disease 2019: A case series and review of the literature
por: Hashim, Zia, et al.
Publicado: (2022) -
Circulating tumor cells and microemboli can differentiate malignant and benign pulmonary lesions
por: Mascalchi, Mario, et al.
Publicado: (2017)